Ergocalciferols
-
Subject Areas on Research
- 1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism.
- Activated injectable vitamin D and hemodialysis survival: a historical cohort study.
- Differential effects of vitamin d receptor agonists on gene expression in neonatal rat cardiomyocytes.
- Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients.
- Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD.
- Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study.
- Oral paricalcitol (19-nor-1,25-dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer: a feasibility trial.
- Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study.
- Paricalcitol, calcitriol, and survival of patients undergoing hemodialysis.
- Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.
- The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia.
- Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.